Main Menu
Congenital adrenal hyperplasia (CAH) is a group of inherited disorders that affect the adrenal glands’ production of cortisol and, in some cases, aldosterone. These hormones help regulate stress responses, blood pressure, and the body’s salt balance. The National Library of Medicine’s GeneReviews estimates that classic 21-hydroxylase deficiency occurs in roughly 1 in 14,000 to 18,000 births, although rates vary among populations. That figure describes one major form, not every type of CAH.
The most common cause is 21-hydroxylase deficiency. Its classic forms include salt-wasting and simple virilizing CAH; a milder, nonclassic form may become apparent later in life. Less common types involve other enzyme deficiencies, so symptoms and medical needs can differ. Endocrine Society guideline author Phyllis W. Speiser and colleagues describe how “the clinical manifestations of CAH due to 21-hydroxylase deficiency vary widely, depending on the degree of enzyme deficiency” (Journal of Clinical Endocrinology & Metabolism, 2018). The distinction is important. A newborn with salt-wasting CAH may lose dangerous amounts of salt, while someone with nonclassic CAH may have subtler signs. One label cannot tell the whole story. This guide explains what CAH is, how its main types differ, and why accurate diagnosis matters. Clinical details can be easy to oversimplify; individual assessment remains essential.
Congenital adrenal hyperplasia (CAH) is a group of inherited conditions affecting the adrenal glands, which sit above the kidneys. In most cases, an enzyme needed to make cortisol works poorly or is missing. The body may then produce excess adrenal androgens. Some forms also limit aldosterone, a hormone that helps regulate salt and fluid balance. It begins before birth. That matters.
The most common type is 21-hydroxylase deficiency, responsible for about 95% of CAH cases. The Endocrine Society’s 2018 clinical practice guideline puts classic CAH incidence at roughly 1 in 15,000 births in the United States. Classic forms can cause salt loss and serious illness in infancy; signs may include vomiting, dehydration, or poor weight gain. Nonclassic CAH is usually milder and may become apparent later, sometimes through early pubic hair or irregular periods. Symptoms and severity vary, so one description cannot fit everyone. Even the word “mild” can be misleading: individual effects differ, and clinical assessment matters.
Congenital adrenal hyperplasia (CAH) is a group of inherited conditions that affect the adrenal glands’ production of steroid hormones, including cortisol, aldosterone, and sex hormones. The specific enzyme affected determines the hormone pattern and symptoms. Most forms are inherited in an autosomal recessive pattern.
| Type of CAH | Enzyme or protein affected | Typical hormone pattern | Common features |
|---|---|---|---|
| 21-hydroxylase deficiency Most common type | 21-hydroxylase (CYP21A2) | Reduced cortisol; aldosterone may also be reduced. Adrenal androgens are often increased. | Classic forms may cause salt-wasting illness or androgen-related genital differences and early androgen effects. The nonclassic form is usually milder and may appear later. |
| 11β-hydroxylase deficiency | 11β-hydroxylase (CYP11B1) | Reduced cortisol; adrenal androgens and deoxycorticosterone (DOC) are increased. | Androgen effects may occur. Excess DOC can contribute to high blood pressure and low potassium; salt-wasting is not typical. |
| 17α-hydroxylase/17,20-lyase deficiency | 17α-hydroxylase/17,20-lyase (CYP17A1) | Reduced sex steroids and cortisol production; mineralocorticoid-active precursors may be increased. | May cause high blood pressure, low potassium, and delayed or atypical pubertal development. Effects on sexual development vary by chromosomal sex and degree of enzyme impairment. |
| 3β-hydroxysteroid dehydrogenase type 2 deficiency | 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) | Production of cortisol, aldosterone, and sex steroids can be impaired; steroid precursors may accumulate. | Severe cases can cause salt-wasting adrenal insufficiency. Differences in genital development or sexual development may occur. |
| StAR or cholesterol side-chain cleavage deficiency | Steroidogenic acute regulatory protein (StAR) or cholesterol side-chain cleavage enzyme (CYP11A1) | Steroid hormone production is broadly reduced because cholesterol transport or its conversion to pregnenolone is impaired. | Can cause severe adrenal insufficiency and salt loss. Effects on sexual development depend on the specific condition and severity. |
| P450 oxidoreductase deficiency | P450 oxidoreductase (POR) | Steroid production may show a mixed pattern because several steroid-producing enzymes are affected. | May cause differences in genital development and, in some people, characteristic skeletal differences. Hormone effects vary. |
Note: Symptoms and severity vary, including among people with the same type of CAH. Diagnosis may involve newborn screening, hormone tests, and sometimes genetic testing. This table is for general information and is not a substitute for medical advice.
Congenital adrenal hyperplasia (CAH) develops when inherited changes disrupt enzymes used to make adrenal hormones. The adrenal glands sit above the kidneys. In the most common form, 21-hydroxylase deficiency, the body makes too little cortisol and sometimes too little aldosterone. Hormone precursors can then build up, increasing androgen production. Effects range from salt loss and dehydration in infancy to milder symptoms that appear later. It varies.
The Endocrine Society’s 2018 clinical practice guideline reports that classic CAH affects about 1 in 15,000 to 1 in 16,000 births. Most cases result from changes in the CYP21A2 gene and follow an autosomal recessive pattern. A child typically inherits one altered copy from each parent. When both parents are carriers, each pregnancy has a 25% chance of CAH, a 50% chance of carrier status, and a 25% chance of inheriting neither altered copy. These are probabilities, not predictions for an individual child.
Genetic testing can help clarify the diagnosis and family risk. Yet CYP21A2 testing can be complex because the gene lies near a similar, inactive sequence. Test results need careful interpretation alongside hormone tests and clinical findings. The biology is not always as tidy as a chart suggests.
Congenital adrenal hyperplasia (CAH) describes a group of inherited conditions that affect adrenal hormone production. Most cases result from reduced activity of the enzyme 21-hydroxylase. The amount of enzyme activity helps shape the condition’s type and severity. The labels are useful, but real symptoms do not always fit neatly.
Classic CAH includes salt-wasting and simple virilizing forms. In salt-wasting CAH, the body may produce too little aldosterone, which helps regulate salt and fluid balance. An affected newborn can develop poor feeding, vomiting, dehydration, or abnormal blood salt levels. This can become urgent. Simple virilizing CAH also involves excess adrenal androgens, but usually causes less severe salt loss. Some babies have differences in genital development; others show signs later, such as rapid growth or early pubic hair.
Nonclassic CAH is generally milder and may appear in childhood, adolescence, or adulthood. Symptoms can include early body hair, acne, or irregular menstrual periods, though some people have few symptoms. Less common enzyme deficiencies can also cause CAH. They may affect blood pressure, puberty, or development in different ways. Careful testing matters, since symptoms alone cannot reliably identify the specific type. Even then, a diagnosis is not a perfect forecast of how one person will feel.
What Is CAH and What Are Its Types?
Symptoms and Diagnosis of CAH
Congenital adrenal hyperplasia (CAH) is a group of inherited conditions that affect adrenal hormone production. Classic CAH may cause salt-wasting, with dangerous fluid and electrolyte loss, or a milder form called simple virilizing CAH. Nonclassic CAH often appears later. Symptoms vary, and they are not always textbook.
In newborns, warning signs can include poor feeding, vomiting, dehydration, or unusual genital development. These symptoms need prompt medical assessment. Children may develop early pubic hair or grow quickly, then stop growing sooner than expected. In adolescents and adults, nonclassic CAH may involve acne, excess facial or body hair, or irregular periods. The Endocrine Society’s 2018 clinical practice guideline describes newborn screening and hormone testing as key parts of evaluation.
Screening is not a diagnosis. Premature or unwell babies can have elevated screening results, so clinicians interpret them carefully. Follow-up may measure 17-hydroxyprogesterone, electrolytes, and renin; an ACTH stimulation test can help confirm the diagnosis. A genetic test may be considered when results remain unclear. Classic CAH is estimated to affect about 1 in 10,000 to 20,000 births, though rates vary by population (NIH MedlinePlus Genetics). Families should ask how a result was confirmed, not rely on one screening number alone. That detail can be easy to miss.
Congenital adrenal hyperplasia (CAH) is a group of inherited conditions that affect hormone production in the adrenal glands. 21-hydroxylase deficiency causes about 95% of cases; other enzyme deficiencies account for the remainder.
These percentages are approximate. Symptoms vary by CAH type and severity and may include atypical genital development, early signs of androgen excess, or salt-wasting crises. Diagnosis may involve newborn screening and blood tests such as 17-hydroxyprogesterone and electrolytes; further hormone or genetic testing can help confirm the type.
CAH care is tailored to the specific type, symptoms, age, and test results. Many people with classic CAH take daily glucocorticoid medicine to replace cortisol and control excess adrenal hormones. Some also need mineralocorticoid medicine and extra salt, especially in infancy. People with nonclassic CAH may not need daily treatment if they have no troubling symptoms. The plan can change over time.
During fever, vomiting, surgery, or serious injury, some patients need adjusted medicine to prevent an adrenal crisis. Their care team should provide clear sick-day instructions and explain when emergency treatment is needed. Keep the plan accessible at home and school. Practice it, even when everyone feels well. Small details matter.
Long-term follow-up usually includes checks of growth, blood pressure, symptoms, and blood or urine tests. Children may see an endocrinologist regularly; adults also need ongoing care. Treatment aims to support health without using more medicine than needed, which can be a difficult balance. Bone health, puberty, menstrual concerns, fertility, and emotional well-being may also deserve discussion. Medication routines can become tiring, especially during travel or illness. Tell the clinician when the plan feels hard to follow; adjustments and practical support may help. Never stop prescribed steroid medicine suddenly without medical advice.
Office: (281) 855-2218
Copyright © 2025 Telco Intercontinental Corp. All rights reserved. Privacy Policy | Legal Disclaimer
Telco®, TelcoMotion®, and TelcoGreen® are registered trademarks of Telco Intercontinental Corp.